Sitafloxacin Hydrate

西他沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameSitafloxacin Hydrate
Drug Alias Namesitafloxacinum西他沙星水合物西塔沙星sitafloxacinesitafloxacino +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsRejection of renal transplantationAcute BronchitisCommunity Acquired Pneumonia +[27] 
Global Approved IndicationsAcute BronchitisUterine CervicitisCystitis +[16] 
Approved Indications in ChinaAcute BronchitisUterine CervicitisCystitis +[15] 
Original Approved Country/TerritoryJapan
Original Approved Date2008/01/25
Country/TerritoryThailandMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKhon Kaen UniversityDaiichi Sankyo Co LtdGaorui Yaoye (Beijing) Technologies Co Ltd +[7] 
Inactive CompaniesCMIC CMO Co Ltd Shizuoka PlantHainan Hualon Pharmaceutical Co LtdDaiichi Sankyo Pharmaceutical (Beijing) Co Ltd
Active IndicationsRejection of renal transplantationAcute BronchitisUterine Cervicitis +[23] 
Inactive IndicationsCommunity Acquired PneumoniaPulmonary Disease, Chronic ObstructiveCommunity-Acquired Infections +[4] 

Other Information

ATC CodeJ01MA21
Related LinksWikipediaDrugBankKEGG